Efficacy and safety of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes: a systematic review and network meta-analysis study protocol

INTRODUCTION: Sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) are two classes of glucose-lowering drugs gaining popularity in the treatment of type 2 diabetes mellitus (T2DM). Current guidelines suggest patient-centred approaches when dec...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open
Autors principals: Hussein, Humaira, Zaccardi, Francesco, Dhalwani, Nafeesa N, Davies, Melanie J, Khunti, Kamlesh, Gray, Laura J
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2018
Matèries:
Diabetes and Endocrinology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6231581/
https://ncbi.nlm.nih.gov/pubmed/30413509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2018-023206
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars